IL141479A0 - Substituted phenyl derivatives, their preparation and use - Google Patents

Substituted phenyl derivatives, their preparation and use

Info

Publication number: IL141479A0
Authority: IL; Israel
Prior art keywords: preparation; substituted phenyl; phenyl derivatives; derivatives; substituted
Prior art date: 1998-10-22

Application number

IL14147999A

Other languages

English (en)

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-10-22

Filing date

1999-10-19

Publication date

2002-03-10

1999-10-19 Application filed by Neurosearch As filed Critical Neurosearch As

2002-03-10 Publication of IL141479A0 publication Critical patent/IL141479A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/30—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by halogen atoms, or by nitro or nitroso groups
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Ophthalmology & Optometry (AREA)
Diabetes (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Oncology (AREA)
Immunology (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)

IL14147999A 1998-10-22 1999-10-19 Substituted phenyl derivatives, their preparation and use IL141479A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DKPA199801362		1998-10-22
PCT/DK1999/000575 WO2000024707A1 (en)	1998-10-22	1999-10-19	Substituted phenyl derivatives, their preparation and use

Publications (1)

Publication Number	Publication Date
IL141479A0 true IL141479A0 (en)	2002-03-10

Family

ID=8104026

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL14147999A IL141479A0 (en)	1998-10-22	1999-10-19	Substituted phenyl derivatives, their preparation and use
IL141479A IL141479A (en)	1998-10-22	2001-02-16	History of Transformed Phenyl, Their Preparation and Use

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL141479A IL141479A (en)	1998-10-22	2001-02-16	History of Transformed Phenyl, Their Preparation and Use

Country Status (28)

Country	Link
US (1)	US6706749B2 (xx)
EP (2)	EP1514867A3 (xx)
JP (2)	JP3960754B2 (xx)
KR (1)	KR100799892B1 (xx)
CN (1)	CN1263733C (xx)
AP (1)	AP2001002103A0 (xx)
AT (1)	ATE286021T1 (xx)
AU (1)	AU759275B2 (xx)
BR (1)	BR9914638A (xx)
CA (1)	CA2342626A1 (xx)
DE (1)	DE69922986T2 (xx)
EE (1)	EE04849B1 (xx)
ES (1)	ES2235522T3 (xx)
HK (1)	HK1040699A1 (xx)
HU (1)	HUP0103673A3 (xx)
IL (2)	IL141479A0 (xx)
IS (1)	IS2215B (xx)
NO (1)	NO20011956D0 (xx)
NZ (1)	NZ510098A (xx)
OA (1)	OA11665A (xx)
PL (1)	PL198852B1 (xx)
PT (1)	PT1123274E (xx)
RU (1)	RU2218328C2 (xx)
SK (1)	SK5222001A3 (xx)
TR (1)	TR200101126T2 (xx)
UA (1)	UA73284C2 (xx)
WO (1)	WO2000024707A1 (xx)
ZA (1)	ZA200101824B (xx)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10102977A1 (de)	2001-01-23	2002-08-01	Thomas Jentsch	Testsystem zur Entwicklung von Therapeutika, insbesondere von Wirkstoffen zur Behandlung von Osteoporose
EP1360504B1 (en) *	2001-01-23	2006-09-13	Pharmos Bioscience A/S	Method for screening compounds for activity in treating an osteoclast related bone disease
US20050080112A1 (en) *	2001-06-22	2005-04-14	Madsen Lars Siim	Compounds for use in disorders associated with mast cell or basophil acitvity
WO2003014727A1 (fr) *	2001-08-08	2003-02-20	Chugai Seiyaku Kabushiki Kaisha	Medicaments pour maladies cardiaque
US7087631B2 (en)	2002-07-18	2006-08-08	Inotek Pharmaceuticals Corporation	Aryltetrazole compounds, and compositions thereof
US7078423B2 (en)	2002-07-18	2006-07-18	Inotek Pharmaceuticals Corporation	5-Aryltetrazole compounds, compositions thereof, and uses therefor
US7291603B2 (en)	2002-07-24	2007-11-06	Ptc Therapeutics, Inc.	Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations
WO2004012733A2 (en) *	2002-08-01	2004-02-12	Neurosearch A/S	Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy
MXPA05002493A (es) *	2002-09-05	2005-05-27	Neurosearch As	Derivados de diarilurea y su uso como bloqueadores del canal del cloro.
WO2004022525A1 (en) *	2002-09-05	2004-03-18	Neurosearch A/S	Amide derivatives and their use as chloride channel blockers
AU2003280308A1 (en)	2002-11-21	2004-06-15	Neurosearch A/S	Aryl ureido derivatives and their medical use
WO2004058722A1 (en) *	2002-12-24	2004-07-15	Arena Pharmaceuticals, Inc.	Diarylamine and arylheteroarylamine pyrazole derivatives as modulators of 5ht2a
JP2006527735A (ja)	2003-06-17	2006-12-07	ノイロサーチアクティーゼルスカブ	ジフェニル尿素誘導体、及びクロライドチャネル遮断剤としてのそれらの使用
TW200523253A (en)	2003-07-22	2005-07-16	Arena Pharm Inc	Diaryl and arylheteroaryl urea derivatives as modulators of the 5-ht2a serotonin receptor useful for the prophylaxis and treatment of disorders related thereto
WO2005023238A1 (en) *	2003-09-04	2005-03-17	Poseidon Pharmaceuticals A/S	Erg channel openers for the treatment of hyperexcitability-related neuronal diseases
EP1663192B1 (en)	2003-09-04	2008-12-03	NeuroSearch A/S	hERG1 CHANNEL OPENERS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS
CA2559038C (en) *	2004-03-23	2013-09-10	Arena Pharmaceuticals, Inc.	Processes for preparing substituted n-aryl-n'-[3-(1h-pyrazol-5-yl) phenyl] ureas and intermediates thereof
US8084459B2 (en)	2004-04-02	2011-12-27	Prana Biotechnology Ltd	Substituted quinazolinones for treating neurological conditions
KR101168451B1 (ko) *	2004-05-12	2012-07-25	프로테오테크, 인크.	아밀로이드 병 및 시뉴클레인 병의 치료를 위한 치환된 ｎ-아릴 벤즈아미드 및 관련 화합물
SA05260357B1 (ar)	2004-11-19	2008-09-08	ارينا فارماسيتو تيكالز ، أنك	مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به
US20080015223A1 (en) *	2004-12-03	2008-01-17	Arena Pharmaceuticals, Inc.	Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto
TWI367098B (en) *	2004-12-23	2012-07-01	Kowa Co	Treating agent for glaucoma
PL1858877T3 (pl)	2005-01-14	2014-08-29	Gilead Connecticut Inc	1,3 podstawione diarylem moczniki jako modulatory aktywności kinazy
CN101160127A (zh) *	2005-01-19	2008-04-09	艾尼纳制药公司	用于预防或治疗进行性多灶性白质脑病而作为5-ht2a血清素受体调节剂的二芳基和芳基杂芳基脲衍生物
US7777040B2 (en)	2005-05-03	2010-08-17	Cgi Pharmaceuticals, Inc.	Certain substituted ureas, as modulators of kinase activity
KR20080103106A (ko)	2006-03-14	2008-11-26	뉴로서치 에이/에스	디페닐우레아 유도체 및 클로라이드 채널 차단제 또는 ＢＫＣａ 채널 조정자로서의 이의 용도
BRPI0722382A2 (pt)	2006-04-14	2012-06-05	Prana Biotechnology Ltd	compostos úteis para o tratamento de cáncer
EP2018371B1 (en)	2006-05-18	2015-03-04	Arena Pharmaceuticals, Inc.	Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
CN102827081A (zh)	2006-05-18	2012-12-19	艾尼纳制药公司	用作5-ht2a 血清素受体调节剂的苯基-吡唑的晶型和其制备方法
EP2027119A2 (en)	2006-05-18	2009-02-25	Arena Pharmaceuticals, Inc.	Ethers, secondary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
TWI415845B (zh) *	2006-10-03	2013-11-21	Arena Pharm Inc	用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物
WO2009023253A2 (en)	2007-08-15	2009-02-19	Arena Pharmaceuticals Inc.	IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
EP2212303A1 (en) *	2007-11-26	2010-08-04	NeuroSearch AS	Novel benzamide derivatives useful as potassium channel modulators
US20110021538A1 (en)	2008-04-02	2011-01-27	Arena Pharmaceuticals, Inc.	Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
US9126946B2 (en)	2008-10-28	2015-09-08	Arena Pharmaceuticals, Inc.	Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto
LT2364142T (lt) *	2008-10-28	2018-06-25	Arena Pharmaceuticals, Inc.	5-ht2a serotonino receptoriaus moduliatoriaus kompozicijos, naudotinos su juo susijusių sutrikimų gydymui
WO2011022028A2 (en) *	2009-05-18	2011-02-24	Tufts University	Small molecule antagonists of phosphatidylinositol-3, 4, 5-triphosphate (pip3) and uses thereof
GB0915196D0 (en)	2009-09-01	2009-10-07	King S College London	Therapeutic compounds and their use
US8980891B2 (en)	2009-12-18	2015-03-17	Arena Pharmaceuticals, Inc.	Crystalline forms of certain 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
US20120208855A1 (en) *	2010-07-12	2012-08-16	Sanofi	Amino-benzoic acid derivatives for use in the treatment of dihydrogenase-related disorders
US9834537B2 (en)	2013-11-27	2017-12-05	Korea Institute Of Science And Technology	Compounds as chloride channel blocking agent
WO2016001452A1 (en) *	2014-07-04	2016-01-07	Universität Zürich	Compounds, in particular for use in the treatment of a disease or condition for which a bromodomain inhibitor is indicated
RU2017145976A (ru)	2015-06-12	2019-07-15	Аксовант Сайенсиз Гмбх	Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна
CN108472285A (zh)	2015-07-15	2018-08-31	阿速万科学有限责任公司	用于预防和治疗与神经退行性疾病相关联的幻觉的二芳基和芳基杂芳基脲衍生物
BR112018073518A2 (pt)	2016-05-17	2019-03-19	Scandion Oncology A/S	métodos para sensibilização de células de câncer a um tratamento anticâncer, para potencialização do efeito terapêutico de um tratamento anticâncer e para tratamento de câncer, composição, modulador de canais de ânion regulados por volume, kit de peças, e, uso de um modulador de canais de ânion regulados por volume
EP3651752B1 (en)	2017-07-11	2024-11-20	Vertex Pharmaceuticals Incorporated	Carboxamides as modulators of sodium channels
JP2023541153A (ja) *	2020-09-14	2023-09-28	ジェンザイム・コーポレーション	鎌状赤血球症を処置するための、ビスホスホグリセリン酸ムターゼのモジュレーターとしてのカルボン酸含有化合物
WO2022263404A1 (en)	2021-06-14	2022-12-22	Scandion Oncology A/S	Methods of increasing the plasma drug exposure of anticancer agents
EP4104834A1 (en)	2021-06-14	2022-12-21	Scandion Oncology A/S	Combination treatments for cancer patients and methods for identifying same
WO2022263411A1 (en)	2021-06-14	2022-12-22	Scandion Oncology A/S	Combination treatments for cancer patients and methods for identifying same
TW202321205A (zh)	2021-07-16	2023-06-01	丹麥商斯坎丁腫瘤公司	Sco-101的熱力穩定形式
CN117229258B (zh) *	2022-06-07	2024-07-19	杭州壹瑞医药科技有限公司	N-四唑基芳基脲类衍生物及其制备方法和应用
WO2024013058A1 (en)	2022-07-11	2024-01-18	Scandion Oncology A/S	Salts of sco-101 and methods involving salts

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB1055786A (en) *	1963-07-12	1967-01-18	Ici Ltd	Urea derivatives
FR2100943A1 (en) *	1970-07-23	1972-03-24	Ici Ltd	O-carboylcarbanilides from anthranilic acid and substd - isocyanates - immuno-suppressive agents
DE2928485A1 (de) *	1979-07-14	1981-01-29	Bayer Ag	Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
CA1156250A (en) *	1979-10-15	1983-11-01	Eastman Kodak Company	Cyan dye-forming couplers
ATE68785T1 (de)	1985-07-31	1991-11-15	Hoechst Ag	N-substituierte 5-nitroanthranilsaeuren, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen.
US4889612A (en)	1987-05-22	1989-12-26	Abbott Laboratories	Ion-selective electrode having a non-metal sensing element
US4921997A (en) *	1988-06-15	1990-05-01	Montefiore Medical Center	Method of synthesis and novel compounds for pharmaceutical uses
WO1991013874A1 (fr)	1990-03-07	1991-09-19	Rhone-Poulenc Rorer S.A.	Derives de glycinamide, leur preparation et les medicaments les contenant
US5489612A (en)	1991-08-23	1996-02-06	The University Of Alabama At Birmingham Research Foundation	Calixarene chloride-channel blockers
US5273992A (en)	1992-11-02	1993-12-28	Beth Israel Hospital Assoc. Inc.	Method for reducing sickle erythrocyte dehydration and delaying the occurrence of erythrocyte sickling in-situ
DK41193D0 (da) *	1993-04-07	1993-04-07	Neurosearch As	Ionkanalaabnere
CA2137755C (en) *	1994-06-07	2002-07-02	William H. Waugh	Palliation of sickle cell disorders by phenylurea, benzylurea, or phenylethylurea or by a homolog ring-substituted with one methoxyl, methyl, or hydroxyl radical
US5559151A (en)	1994-11-30	1996-09-24	Allergan	Method for reducing intraocular pressure in the mammalian eye by administration of chloride channel blockers
DE4447096C2 (de) *	1994-12-29	1998-12-03	Rehau Ag & Co	Stabilisierte chlorhaltige Polymerisate und Verwendung von funktionellen Harnstoff-Derivaten als Stabilisatoren
EP0809492A4 (en) *	1995-02-17	2007-01-24	Smithkline Beecham Corp	IL-8 RECEPTOR ANTAGONISTS
US5773459A (en) *	1995-06-07	1998-06-30	Sugen, Inc.	Urea- and thiourea-type compounds
BR9708735A (pt) *	1996-04-23	1999-08-03	Vertex Pharma	Derivados de uréia como inibidores da enzina impdh
DE69716424T2 (de) *	1996-05-24	2003-02-20	Neurosearch A/S, Ballerup	Saure gruppen enthaltende phenylderivate, ihre herstellung und ihre verwendung als chloridkanalblocker
CZ295822B6 (cs) *	1997-04-22	2005-11-16	Neurosearch A/S	Substituované fenylderiváty, způsob jejich přípravy a použití a farmaceutické přípravky s jejich obsahem
US6093742A (en) *	1997-06-27	2000-07-25	Vertex Pharmaceuticals, Inc.	Inhibitors of p38
EP1616865A1 (en) *	1997-12-22	2006-01-18	Bayer Pharmaceuticals Corporation	Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas

1999
- 1999-10-19 AP APAP/P/2001/002103A patent/AP2001002103A0/en unknown
- 1999-10-19 JP JP2000578279A patent/JP3960754B2/ja not_active Expired - Fee Related
- 1999-10-19 RU RU2001107853/04A patent/RU2218328C2/ru not_active IP Right Cessation
- 1999-10-19 NZ NZ510098A patent/NZ510098A/en unknown
- 1999-10-19 TR TR2001/01126T patent/TR200101126T2/xx unknown
- 1999-10-19 ZA ZA200101824A patent/ZA200101824B/en unknown
- 1999-10-19 PT PT99950505T patent/PT1123274E/pt unknown
- 1999-10-19 UA UA2001021084A patent/UA73284C2/uk unknown
- 1999-10-19 AT AT99950505T patent/ATE286021T1/de not_active IP Right Cessation
- 1999-10-19 KR KR1020017004970A patent/KR100799892B1/ko not_active IP Right Cessation
- 1999-10-19 DE DE69922986T patent/DE69922986T2/de not_active Expired - Lifetime
- 1999-10-19 OA OA1200100094A patent/OA11665A/en unknown
- 1999-10-19 ES ES99950505T patent/ES2235522T3/es not_active Expired - Lifetime
- 1999-10-19 SK SK522-2001A patent/SK5222001A3/sk unknown
- 1999-10-19 CA CA002342626A patent/CA2342626A1/en not_active Abandoned
- 1999-10-19 BR BR9914638-0A patent/BR9914638A/pt not_active Application Discontinuation
- 1999-10-19 HU HU0103673A patent/HUP0103673A3/hu unknown
- 1999-10-19 EP EP04105861A patent/EP1514867A3/en not_active Withdrawn
- 1999-10-19 WO PCT/DK1999/000575 patent/WO2000024707A1/en active IP Right Grant
- 1999-10-19 PL PL347371A patent/PL198852B1/pl unknown
- 1999-10-19 EE EEP200100185A patent/EE04849B1/xx not_active IP Right Cessation
- 1999-10-19 AU AU63259/99A patent/AU759275B2/en not_active Ceased
- 1999-10-19 EP EP99950505A patent/EP1123274B1/en not_active Expired - Lifetime
- 1999-10-19 CN CNB998117730A patent/CN1263733C/zh not_active Expired - Fee Related
- 1999-10-19 IL IL14147999A patent/IL141479A0/xx active IP Right Grant
2001
- 2001-02-16 IL IL141479A patent/IL141479A/en not_active IP Right Cessation
- 2001-03-02 IS IS5875A patent/IS2215B/is unknown
- 2001-04-19 US US09/837,166 patent/US6706749B2/en not_active Expired - Fee Related
- 2001-04-20 NO NO20011956A patent/NO20011956D0/no not_active Application Discontinuation
2002
- 2002-03-19 HK HK02102082A patent/HK1040699A1/xx not_active IP Right Cessation
2003
- 2003-01-30 JP JP2003022576A patent/JP2003246773A/ja not_active Abandoned

Also Published As

Publication number	Publication date
IS2215B (is)	2007-03-15
AU6325999A (en)	2000-05-15
HUP0103673A3 (en)	2003-03-28
CN1322194A (zh)	2001-11-14
DE69922986D1 (de)	2005-02-03
UA73284C2 (en)	2005-07-15
EP1123274B1 (en)	2004-12-29
NO20011956L (no)	2001-04-20
SK5222001A3 (en)	2002-05-09
US20020032210A1 (en)	2002-03-14
EP1123274A1 (en)	2001-08-16
ES2235522T3 (es)	2005-07-01
JP2002528432A (ja)	2002-09-03
HUP0103673A2 (hu)	2002-02-28
TR200101126T2 (tr)	2001-09-21
CN1263733C (zh)	2006-07-12
OA11665A (en)	2004-12-08
PL198852B1 (pl)	2008-07-31
HK1040699A1 (en)	2002-06-21
PT1123274E (pt)	2005-04-29
AU759275B2 (en)	2003-04-10
EE200100185A (et)	2002-08-15
IS5875A (is)	2001-03-02
IL141479A (en)	2006-08-20
EE04849B1 (et)	2007-06-15
WO2000024707A1 (en)	2000-05-04
PL347371A1 (en)	2002-04-08
ATE286021T1 (de)	2005-01-15
US6706749B2 (en)	2004-03-16
ZA200101824B (en)	2002-03-05
EP1514867A2 (en)	2005-03-16
BR9914638A (pt)	2001-07-03
JP2003246773A (ja)	2003-09-02
KR100799892B1 (ko)	2008-01-31
RU2218328C2 (ru)	2003-12-10
KR20010080270A (ko)	2001-08-22
AP2001002103A0 (en)	2001-03-31
DE69922986T2 (de)	2005-07-07
EP1514867A3 (en)	2005-03-23
NZ510098A (en)	2003-09-26
NO20011956D0 (no)	2001-04-20
JP3960754B2 (ja)	2007-08-15
CA2342626A1 (en)	2000-05-04

Publication	Publication Date	Title
HUP0103673A3 (en)	2003-03-28	Substituted phenyl derivatives, their preparation and use
PL351312A1 (en)	2003-04-07	New compounds, their preparation and use
AU6325599A (en)	2000-05-08	New compounds, their preparation and use
AU6325899A (en)	2000-05-08	New compounds, their preparation and use
AU6190199A (en)	2000-05-08	New compounds, their preparation and use
AU6325799A (en)	2000-05-08	New compounds, their preparation and use
AU6190299A (en)	2000-05-08	New compounds, their preparation and use
AU6325699A (en)	2000-05-08	New compounds, their preparation and use
HK1048999A1 (zh)	2003-04-25	氮雜䓬吲衍生物，它們的製備和應用
HK1042084A1 (en)	2002-08-02	Substituted benzimidazoles and their preparation and use.
PL351250A1 (en)	2003-04-07	Antipicornaviral compounds, their preparation and use
AU3958100A (en)	2000-11-02	New compounds, their preparation and use
AU3958200A (en)	2000-11-02	New compounds, their preparation and use
PL344412A1 (en)	2001-11-05	Pyrazoline derivatives, their preparation and application as medicaments
AU3957900A (en)	2000-11-02	New compounds, their preparation and use
HK1078561A1 (en)	2006-03-17	Novel compounds, their use and preparation
GB9817235D0 (en)	1998-10-07	Compound,composition and use
IL135451A0 (en)	2001-05-20	3-amino-3-arylpropan-1-ol derivatives, their preparation and use
AU3595099A (en)	1999-11-29	New compounds, their preparation and use
GB9817236D0 (en)	1998-10-07	Compound,composition and use
GB9903447D0 (en)	1999-04-07	Compound, composition and use
IL143082A0 (en)	2002-04-21	Benzofuran derivatives, their preparation and use
GB0100361D0 (en)	2001-02-14	Compound, composition and use
HUP0000491A3 (en)	2001-12-28	Herbicidal substituted 4-benzoyl-pyrazole derivatives, preparation and use thereof
IL135452A0 (en)	2001-05-20	3-amino-3-arylpropan-1-ol derivatives, their preparation and use

Legal Events

Date	Code	Title	Description
2007-02-12	FF	Patent granted
2007-03-08	KB	Patent renewed